Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]

K. Mihajluk, C. Simms, M. Reay, P.A. Madureira, A. Howarth, P. Murray, S. Nasser, C.A. Duckworth, D.M. Pritchard, G.J. Pilkington, R. Hill

Research output: Contribution to journalComment/debatepeer-review

164 Downloads (Pure)
Original languageEnglish
JournalCancer Letters
Publication statusEarly online - 8 Oct 2019

Cite this